Not Yet Recruiting
RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer
NCT07735624
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States